中国仓鼠卵巢细胞
生物过程
单克隆抗体
细胞培养
监测和控制
生物
细胞生物学
下游加工
计算生物学
生物技术
抗体
生物化学
免疫学
工程类
古生物学
控制工程
遗传学
作者
Catherine E.M. Hogwood,Daniel G. Bracewell,C. Mark Smales
标识
DOI:10.1016/j.copbio.2014.06.017
摘要
Chinese hamster ovary (CHO) cells are widely used for the production of biotherapeutic recombinant proteins for a range of molecules including monoclonal antibodies and Fc-fusion proteins. Regulatory requirements for the final product include the removal of host cell proteins (HCPs) to acceptable amounts (<100ppm). Recent research has begun to unravel the extent to which upstream process conditions and subsequent product recovery and purification processes impact upon the HCP profile. A number of upstream parameters, including the selection of the cell line, the culturing process (e.g. feeding regime, culture temperature), cell viability at time of harvest/culture duration and cell shear sensitivity can all influence the resulting HCP profile. Further, the molecule itself plays an important role in determining those HCPs that are retained throughout a bioprocess and HCPs can co-elute with the target product during purification. Measurement and monitoring of HCPs is usually undertaken using ELISA technology, however alternative approaches are also now emerging that complement ELISA and allow the detection, identification and monitoring of specific HCPs. Here we discuss our understanding of how the process itself influences those HCPs present throughout the production process and the challenges in their monitoring, measurement and removal.
科研通智能强力驱动
Strongly Powered by AbleSci AI